Agility and better decisions depend on managing risk and gaining insights from data by prioritizing patient and end-user needs. Companies of all sizes, including GSK, Boehringer-Ingelheim, Sanofi, AstraZeneca, and AbbVie, share best practices.
Jim Reilly
Advertisement
Articles by Jim Reilly
Advertisement
Latest Updated Articles
Mastering Patient Centricity’s Moving Parts: Innovators Share Real-World ExamplesPublished: December 2nd 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer’s Stock Reacts to Decreases in 2026 Revenue Projections in Full-Year 2026 Guidance Release
2
Novo Nordisk Submits NDA to FDA for CagriSema
3
Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience
4
The End of the Rebate Era? What HR Leaders and Pharmacy Consultants Need to Know About Biosimilars
5